In Brief This Week: Personalis, Biocartis, Opko Health, Berkeley Lights, More
News items for the week of Feb. 20, 2023.
In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More
News items for the week of Jan. 30, 2023.
Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen
Waters, Personalis, Opko Health, Biodesix, and Exagen reported quarterly financial results this week.
Local Coverage Determinations Roundup: Opko Health, Bio-Techne, LynxDx, MDxHealth
Medicare Administrative Contractor National Government Services released an LCD that would cover prostate cancer tests from multiple diagnostic companies.
Opko Health Posts 19 Percent Drop in Q4 Revenues on COVID-19 Testing Decline
Despite the revenue fall, which was largely driven by a continued slide in COVID-19 testing volume, Opko topped Wall Street analysts' consensus estimate.
Jan 20, 2022
Jan 18, 2022
Sema4 to Acquire GeneDx for $623M
Oct 28, 2021
Opko Health Q3 Revenues Fall 10 Percent
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Mar 10, 2017